[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Mon, Oct 03rd 2022 ]: WOPRAI
[ Sun, Oct 02nd 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Fri, Sep 30th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
[ Thu, Sep 29th 2022 ]: WOPRAI
Kevin Barker Maintained (UWMC) at Sell with Decreased Target to $2.5 on, Sep 30th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Kevin Barker of Piper Sandler, Maintained "UWM Holdings Corporation" (UWMC) at Sell with Decreased Target from $3 to $2.5 on, Sep 30th, 2022.
Kevin has made no other calls on UWMC in the last 4 months.
There are 3 other peers that have a rating on UWMC. Out of the 3 peers that are also analyzing UWMC, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mark Devries of "Barclays" Maintained at Hold with Decreased Target to $4 on, Monday, July 11th, 2022
- Kevin Heal of "Argus Research" Downgraded from Strong Buy to Hold on, Thursday, June 2nd, 2022
This is the rating of the analyst that currently disagrees with Kevin
- Douglas Harter of "Credit Suisse" Downgraded from Hold to Sell and Decreased Target to $3.5 on, Wednesday, August 10th, 2022